Table Of Contents:
1. Market Context & Strategic Relevance
1.1 Opening Context (Why the market matters)
1.1.1 Why This Market Is Gaining Strategic Attention
1.1.2 Business Decisions This Report Supports
1.2 Scope
1.3 Research & Methodology
2. Executive Summary
2.1 Market Snapshot
2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis
2.3 Market Size & Forecast, By Segmentation, 2022–2035
2.3.1 Market Size By Product & Services
2.3.2 Market Size By Type
2.3.3 Market Size By Application
2.3.4 Market Size By End Use
2.4 Market Share & Bps Analysis By Region, 2025
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO's Perspective
3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter's) Impacting Market Growth
3.4 Industry Supply Chain Analysis
3.4.1. Reagent & Library Component Suppliers
3.4.2. CRISPR Screening Reagent & Library Manufacturers
3.4.3. Screening Service Providers & Contract Research Organizations
3.4.4. Pharmaceutical, Biotechnology, Academic & Other End-Users
3.5 Industry Life Cycle Assessment
4. Statistical Insights & Trends Reporting
4.1 Product & Type Adoption Metrics
4.1.1 Products vs. Services Demand Trends
4.1.2 CRISPR Knockout vs. Activation Specification Mix
4.1.3 Pooled vs. Arrayed Screening Format Trends
4.1.4 Library Design Complexity Trends
4.2 Regional Research & Investment Statistics
4.2.1 Academic Genomics Funding by Region
4.2.2 Biopharmaceutical Screening Investment Trends
4.2.3 Government Functional Genomics Initiative Funding
4.2.4 Regional Contract Research Capacity Trends
4.3 Regulatory & Clinical Benchmarking
4.3.1 Gene-Editing Therapy Approval Pathway Trends
4.3.2 Target Validation Regulatory Expectations
4.3.3 Patent & Licensing Dispute Tracking
4.3.4 Clinical Translation Timeline Benchmarking
4.4 Technology & Platform Trends
4.4.1 Single-Cell CRISPR Screening Adoption
4.4.2 AI-Assisted Guide RNA Design Trends
4.4.3 High-Throughput Instrument Platform Trends
4.4.4 Off-Target Analysis Method Trends
4.5 Supply Chain & Competitive Statistics
4.5.1 Reagent Supplier Concentration Trends
4.5.2 Supplier Consolidation & Acquisition Activity
4.5.3 Emerging Market Distribution Expansion
4.5.4 Contract Research Organization Partnership Trends
5. CRISPR Screening Market Segmental Analysis, By Product & Services
5.1 Introduction
5.2 Products
5.2.1 Key Trends
5.2.2 Market Size & Forecast, 2022–2035
5.3 Services
6. CRISPR Screening Market Segmental Analysis, By Type
6.1 Introduction
6.2 CRISPR Knockout
6.2.1 Key Trends
6.2.2 Market Size & Forecast, 2022–2035
6.3 CRISPR Interference
6.4 CRISPR Activation
6.5 Others
7. CRISPR Screening Market Segmental Analysis, By Application
7.1 Introduction
7.2 Functional Genomics
7.2.1 Key Trends
7.2.2 Market Size & Forecast, 2022–2035
7.3 Drug Discovery and Development
7.4 Target Identification and Validation
7.5 Cancer Research
7.6 Genetic Disease Research
8. CRISPR Screening Market Segmental Analysis, By End Use
8.1 Introduction
8.2 Pharmaceutical and Biotechnology Companies
8.2.1 Key Trends
8.2.2 Market Size & Forecast, 2022–2035
8.3 Academic and Research Institutes
8.4 Contract Research Organizations
8.5 Other End Users
9. CRISPR Screening Market Segmental Analysis, By Region
9.1 Introduction
9.2 North America
9.2.1 Key Trends
9.2.2 CRISPR Screening Market Size & Forecast, By Product & Services, 2022–2035
9.2.3 CRISPR Screening Market Size & Forecast, By Type, 2022–2035
9.2.4 CRISPR Screening Market Size & Forecast, By Application, 2022–2035
9.2.5 CRISPR Screening Market Size & Forecast, By End Use, 2022–2035
9.2.6 CRISPR Screening Market Size & Forecast, By Country, 2022–2035
9.2.6.1 US
9.2.6.2 Canada
9.3 Europe
9.3.1 Key Trends
9.3.2 CRISPR Screening Market Size & Forecast, By Product & Services, 2022–2035
9.3.3 CRISPR Screening Market Size & Forecast, By Type, 2022–2035
9.3.4 CRISPR Screening Market Size & Forecast, By Application, 2022–2035
9.3.5 CRISPR Screening Market Size & Forecast, By End Use, 2022–2035
9.3.6 CRISPR Screening Market Size & Forecast, By Country, 2022–2035
9.3.6.1 Germany
9.3.6.2 France
9.3.6.3 UK
9.3.6.4 Italy
9.3.6.5 Spain
9.3.6.6 Poland
9.3.6.7 Russia
9.3.6.8 Rest of Europe
9.4 Asia Pacific
9.4.1 Key Trends
9.4.2 CRISPR Screening Market Size & Forecast, By Product & Services, 2022–2035
9.4.3 CRISPR Screening Market Size & Forecast, By Type, 2022–2035
9.4.4 CRISPR Screening Market Size & Forecast, By Application, 2022–2035
9.4.5 CRISPR Screening Market Size & Forecast, By End Use, 2022–2035
9.4.6 CRISPR Screening Market Size & Forecast, By Country, 2022–2035
9.4.6.1 China
9.4.6.2 India
9.4.6.3 Japan
9.4.6.4 South Korea
9.4.6.5 Australia
9.4.6.6 ASEAN Countries
9.4.6.7 Rest of Asia Pacific
9.5 Latin America
9.5.1 Key Trends
9.5.2 CRISPR Screening Market Size & Forecast, By Product & Services, 2022–2035
9.5.3 CRISPR Screening Market Size & Forecast, By Type, 2022–2035
9.5.4 CRISPR Screening Market Size & Forecast, By Application, 2022–2035
9.5.5 CRISPR Screening Market Size & Forecast, By End Use, 2022–2035
9.5.6 CRISPR Screening Market Size & Forecast, By Country, 2022–2035
9.5.6.1 Brazil
9.5.6.2 Argentina
9.5.6.3 Mexico
9.5.6.4 Colombia
9.5.6.5 Rest of Latin America
9.6 Middle East & Africa
9.6.1 Key Trends
9.6.2 CRISPR Screening Market Size & Forecast, By Product & Services, 2022–2035
9.6.3 CRISPR Screening Market Size & Forecast, By Type, 2022–2035
9.6.4 CRISPR Screening Market Size & Forecast, By Application, 2022–2035
9.6.5 CRISPR Screening Market Size & Forecast, By End Use, 2022–2035
9.6.6 CRISPR Screening Market Size & Forecast, By Country, 2022–2035
9.6.6.1 UAE
9.6.6.2 Saudi Arabia
9.6.6.3 Qatar
9.6.6.4 South Africa
9.6.6.5 Rest of Middle East & Africa
10. Competitive Landscape
10.1 Key Players' Positioning
10.2 Competitive Developments
10.2.1 Year-Wise Strategies & Development, 2022–2026
10.3 Market Share Analysis, 2025
10.4 Product/Service & Application Benchmarking
10.4.1 Product/Service Specifications & Features By Key Players
10.4.2 Product/Service Heatmap By Key Players
10.4.3 Application Heatmap By Key Players
10.5 Industry Start-Up & Innovation Landscape
10.6 Key Company Profiles
10.6.1 Revvity, Inc.
10.6.1.1 Company Overview & Snapshot
10.6.1.2 Product/Service Portfolio
10.6.1.3 Key Company Financials
10.6.1.4 Geographical Presence
10.6.1.5 SWOT Analysis
10.6.2 Thermo Fisher Scientific Inc.
10.6.3 Merck KGaA
10.6.4 Cellecta, Inc.
10.6.5 GeneCopoeia, Inc.
10.6.6 Integrated DNA Technologies, Inc.
10.6.7 bit.bio
10.6.8 Horizon Discovery Ltd.
10.6.9 Applied Biological Materials Inc.
11. Analyst Recommendations
11.1 SNS Insider Opportunity Map
11.2 Industry Low-Hanging Fruit Assessment
11.3 Market Entry & Growth Strategy
11.4 Analyst Viewpoint & Suggestions On Market Growth
12. Assumptions
13. Disclaimer
14. Appendix
14.1 List Of Tables
14.2 List Of Figures
Frequently Asked Questions
The market includes Revvity, Thermo Fisher Scientific, Merck KGaA, Cellecta, GeneCopoeia, Integrated DNA Technologies, bit.bio, Horizon Discovery and Applied Biological Materials, among others. These companies compete on library breadth, reagent quality and screening service capability.
The main opportunities lie in pairing AI-enabled guide RNA design and data analysis tools with existing reagent and library catalogs, and extending accessible screening capability to contract research organizations and smaller biotechnology companies in emerging markets.
The key growth factor is rising demand for the reagents and instruments underpinning genome-scale screening, reinforced by growing commercial validation from approved CRISPR-based therapies that encourages earlier-stage investment in target discovery screening.
By application, the Functional Genomics segment dominated the market with approximately 31.20% share in 2025, supported by its broad, hypothesis-generating use across academic and industry research.
North America dominated the market with approximately 41.80% share in 2025, supported by its dense concentration of pharmaceutical discovery units and academic genome centers. Asia Pacific is the fastest-growing region with a projected CAGR of 18.50% from 2026 to 2035.
